0|875|Public
50|$|XCSs are <b>over-the-counter</b> (<b>OTC)</b> derivatives.|$|R
5000|$|... #Subtitle level 3: <b>Over-the-counter</b> (<b>OTC)</b> {{commodities}} derivatives ...|$|R
5000|$|... 328 et seq. Specific {{requirements}} for <b>over-the-counter</b> (<b>OTC)</b> drugs.|$|R
5000|$|Require {{clearing}} of all standardized <b>over-the-counter</b> (<b>OTC)</b> derivatives through regulated {{central counterparties}} (CCPs); ...|$|R
50|$|Tigas stores {{services}} {{customers with}} drugs, <b>over-the-counter</b> (<b>OTC)</b> medications and fast-moving consumer goods (FMCG).|$|R
5000|$|In 2004, Bayer HealthCare AG {{acquired}} the <b>over-the-counter</b> (<b>OTC)</b> Pharmaceutical Division of Roche Pharmaceuticals.|$|R
5000|$|SGX AsiaClear: offers {{clearing}} {{services for}} <b>over-the-counter</b> (<b>OTC)</b> oil swaps and forward freight agreements.|$|R
5000|$|<b>Over-the-counter</b> (<b>OTC)</b> {{derivative}} contracts: Privately negotiated derivative {{contracts that}} are transacted off organized futures exchanges.|$|R
5000|$|The company {{supported}} the <b>Over-the-Counter</b> (<b>OTC)</b> Hearing Aid Act of 2017, which passed {{both houses of}} Congress ...|$|R
50|$|The {{exchange}} listing {{made these}} products available to {{wider range of}} investors who could not trade <b>over-the-counter</b> (<b>OTC).</b>|$|R
50|$|An {{interest}} rate guarantee (IRG) {{is an option}} on a forward rate agreement (FRA) that is handled <b>over-the-counter</b> (<b>OTC).</b>|$|R
50|$|Wyeth {{manufactured}} <b>over-the-counter</b> (<b>OTC)</b> drugs Robitussin and the analgesic Advil (ibuprofen) {{as well as}} {{prescription drugs}} Premarin and Effexor.|$|R
5000|$|Another {{experiment}} {{consisted of}} establishing securities trading markets such as, <b>over-the-counter</b> (<b>OTC)</b> market for shares and bonds {{was established in}} 1986.|$|R
50|$|In September 2009 Markit and Depository Trust & Clearing Corporation (DTCC) {{launched}} MarkitSERV, a {{joint venture}} to provide <b>over-the-counter</b> (<b>OTC)</b> derivative trade processing.|$|R
50|$|Medherant Ltd is a British {{pharmaceutical}} company currently based in Coventry. The company develops <b>over-the-counter</b> (<b>OTC)</b> and prescription transdermal patches for drug delivery.|$|R
50|$|An orally {{disintegrating}} tablet or orodispersible tablet (ODT), {{is a drug}} dosage form available for a limited range of <b>over-the-counter</b> (<b>OTC)</b> and prescription medications.|$|R
50|$|The Sunscreen Innovation Act would {{amend the}} Federal Food, Drug, and Cosmetic Act to {{establish}} a process for the review and approval of <b>over-the-counter</b> (<b>OTC)</b> sunscreens.|$|R
50|$|In 2000 lebensart Global Networks AG, with Daniel Adams as the CFO raised {{sufficient}} {{capital to}} transfer trading from the <b>over-the-counter</b> (<b>OTC)</b> markets to the Börse München.|$|R
50|$|VEH and VPH {{invests in}} listed {{companies}} on the Ho Chi Minh City Stock Exchange and Hanoi Stock Exchange, <b>over-the-counter</b> (<b>OTC),</b> private companies/development projects and/or debt securities.|$|R
50|$|In 1995, {{developments}} {{and the growth}} of the <b>over-the-counter</b> (<b>O.T.C.)</b> sector led to VIANEX S.A. founding VIAN S.A., in order to distribute its O.T.C. pharmaceutical and non-pharmaceutical products.|$|R
50|$|As of July 8, 2016, Galderma {{received}} {{approval from}} the U.S. Food and Drug Administration (FDA) for Differin Gel (adapalene gel 0.1%) as an <b>over-the-counter</b> (<b>OTC)</b> treatment for acne.|$|R
50|$|In <b>over-the-counter</b> (<b>OTC)</b> {{derivative}} markets, {{two parties}} form an agreement using a unique contract designed to mitigate a specific risk. See Understanding Derivatives: Markets and Infrastructure for more details.|$|R
50|$|Levomethamphetamine is the levorotary (L-enantiomer) form of methamphetamine. Levomethamphetamine is a {{sympathomimetic}} vasoconstrictor {{which is}} the active ingredient in some <b>over-the-counter</b> (<b>OTC)</b> nasal decongestant inhalers in the United States.|$|R
5000|$|<b>Over-the-counter</b> (<b>OTC)</b> {{derivatives}} {{can help}} minimize basis risk {{by creating a}} perfect hedge. This is because OTC derivatives can be tailored to fit the exact risk needs of a hedger.|$|R
50|$|In 2013, Prestige Brands Holdings, Inc. {{acquired}} Care Pharmaceuticals of Bondi Junction, New South Wales Australia, {{a privately}} held marketer and distributor of <b>over-the-counter</b> (<b>OTC)</b> healthcare brands {{for children and}} adults.|$|R
50|$|In September 2010, a 10% {{stake in}} Parsian E-Commerce, the online banking {{subsidiary}} of Parsian Bank, was successfully {{sold on the}} Iranian <b>Over-The-Counter</b> (<b>OTC)</b> market. The IPO was worth $116 million.|$|R
50|$|Harbin Pharmaceutical {{is engaged}} in the research, development, {{manufacture}} and sale of pharmaceutical products. The Company primarily offers antibiotics, Chinese patent medicines, <b>over-the-counter</b> (<b>OTC)</b> medicines, healthcare products and synthesized preparations, among others.|$|R
50|$|In 2007, the United States Food and Drug Administration (FDA) {{mandated}} that labels for nonoxynol-9 <b>over-the-counter</b> (<b>OTC)</b> contraceptive products carry a new warning {{saying they do}} not protect against STDs and HIV/AIDS.|$|R
50|$|It {{is found}} {{in a variety of}} <b>over-the-counter</b> (<b>OTC)</b> {{medications}} as an anti-inflammatory, primarily for back-pain relief. Magnesium salicylate can be an effective OTC alternative to prescription NSAIDs, with both anti-inflammatory and pain-relieving effects.|$|R
50|$|CDER reviews New Drug Applications {{to ensure}} that the drugs are safe and effective. Its primary {{objective}} is {{to ensure that}} all prescription and <b>over-the-counter</b> (<b>OTC)</b> medications are safe and effective when used as directed.|$|R
5000|$|... "True pharmacies" [...] are {{required}} to install an IIAS after June 30, 2009, unless at least 90% of the individual pharmacy's sales are of [...] "FSA-eligible" [...] items, i.e., prescription drugs or <b>over-the-counter</b> (<b>OTC)</b> items.|$|R
5000|$|Derivative {{instruments}} —instruments which {{derive their}} value from {{the value and}} characteristics {{of one or more}} underlying entities such as an asset, index, or interest rate. They can be exchange-traded derivatives and <b>over-the-counter</b> (<b>OTC)</b> derivatives.|$|R
5000|$|With the U.S. Food and Drug Administration (FDA) {{regulations}} concerning tamper-resistant packaging, pharmaceutical packagers {{must find}} ways to comply as outlined in Sec. 450.500 Tamper-Resistant Packaging Requirements for Certain <b>over-the-counter</b> (<b>OTC)</b> Human Drug Products (CPG 7132a.17).|$|R
5000|$|In a {{response}} to US financial crisis in 2008, Sprecher formed ICE US Trust based in New York, now called ICE Clear Credit LLC, {{to serve as a}} limited-purpose bank, a clearing house for credit default swaps. Sprecher worked closely with the Federal Reserve to serve as its <b>over-the-counter</b> (<b>OTC)</b> derivatives clearing house. [...] "US regulators were keen on the kind of clearing house for opaque <b>over-the-counter</b> (<b>OTC)</b> derivatives as a risk management device. In the absence of a central counterparty - which would guarantee pay-outs should a trading party be unable to do so - there was a high risk of massive market disruption".|$|R
50|$|Regulation D {{does not}} emplace the six-time {{transfer}} limit on outbound savings or money market account transactions initiated in person, via messenger or mail; <b>over-the-counter</b> (<b>OTC)</b> withdrawals and transfers, ATM withdrawals and transfers, or installment loan repayments.|$|R
5000|$|Third {{market in}} finance, {{refers to the}} trading of exchange-listed {{securities}} in the <b>over-the-counter</b> (<b>OTC)</b> market. These trades allow institutional investors to trade blocks of securities directly, rather than through an exchange, providing liquidity and anonymity to buyers ...|$|R
